Comparative Genomics and Proteomics in Drug Discovery
Regular price
€80.99
advanced proteomic analysis
Auditory Sensory Gating
Body Wall Muscle
Category=PSAK
comparative genomics in pharmaceutical research
Depolarising Pulses
Disease State Monitoring
Drug Target Discovery
Endogenous Diseases
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
gene family-based approach
GeneCards Database
global drug discovery
HBA2 Gene
HBB Gene
host-pathogen interactions
Insect nAChR
kinetoplastid genomics
Malaria Infection
Malaria Pathogenesis
molecular drug targets
MuSK
nAChR Subtypes
nAChR Subunits
Nicotinic Acetylcholine Receptors
parasitic disease genomics
proteomics
Puff Erf Ish
RNA Editing
Sleeping Sickness
SM
sodium channel inhibitors
Species Specific Genes
Subtelomeric Regions
TNF Polymorphism
translational medicine approaches
Trypanosoma Brucei
Trypanosoma Congolense
Product details
- ISBN 9780367389734
- Weight: 453g
- Dimensions: 156 x 234mm
- Publication Date: 05 Sep 2019
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.
John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.
